AR and prostate carcinoma: Our preliminary study observed that overexpression of NURR1 could increase protein expression of AR and activation of AR signaling in prostate cancer cells (unpublished results), suggesting that there could be a direct positive regulation between two nuclear receptors in prostate cancer cells and with this interaction contributing to potentiation of AR signaling in advanced growth of prostate cancer.